Skip to main content

Major Depression bei organischen Grunderkrankungen

Temporallappenepilepsie, Apoplex, Morbus Parkinson

  • Conference paper
Depression 2000
  • 215 Accesses

Zusammenfassung

Die Komorbidität zwischen somatischen und psychiatrischen Erkrankungen ist nach wie vor weder ausreichend erforscht noch findet sie ausreichende Beachtung in der klinischen Praxis (Maier u. Falkai 1999). Der folgende Beitrag beschäftigt sich mit dem gemeinsamen Auftreten der Major Depression und jeweils einer von drei sehr unterschiedlichen Erkrankungen aus dem nervenärztlichen Stoffgebiet: Temporallappenepilepsie, Apoplex und Morbus Parkinson.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amann B, Erfurth A, Back T, Grunze H (1999) Severe therapy refractory depression as initial manifestation of Parkinson disease. Psychiatr Prax 26:45–47.

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1998) Diagnostisches und Statistisches Manual Psychischer Störungen. DSM-IV, 2. Aufl. Hogrefe, Göttingen.

    Google Scholar 

  • Andersen G, Vestergaard K, Riis JO (1993) Citalopram for post-stroke pathological crying. Lancet 342 (8875):837–839.

    Article  PubMed  CAS  Google Scholar 

  • Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25:1099–1104.

    Article  PubMed  CAS  Google Scholar 

  • Andersen G (1995) Treatment of uncontrolled crying after stroke. Drugs Aging 6:105–111.

    Article  PubMed  CAS  Google Scholar 

  • Andersen G (1997) Post-stroke depression: diagnosis and incidence. Eur Psychiatry 12 (Suppl 3):255–260.

    Article  Google Scholar 

  • Bader JP, Hell D (1998) Parkinson-Syndrom und Depression. Fortschr Neurol Psychiat 66:303–312.

    Article  PubMed  CAS  Google Scholar 

  • Bazire S (1999) Psychotropic drug directory. Quay, Snow Hill.

    Google Scholar 

  • Bleuler E (1943) Lehrbuch der Psychiatrie. Springer, Berlin.

    Google Scholar 

  • Brown RG, MacCarthy B (1990) Psychiatric morbidity in patients with Parkinson’s disease. Psychol Med 20:77–87.

    Article  PubMed  CAS  Google Scholar 

  • Burke WJ, Peterson J, Rubin EH (1988) Electroconvulsive therapy in the treatment of combined depression and Parkinson’s disease. Psychosomatics 29:341–346.

    PubMed  CAS  Google Scholar 

  • Chaslin P (1895) La Confusion mentale primitive. Asselin et Houzeau, Paris.

    Google Scholar 

  • Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454.

    PubMed  CAS  Google Scholar 

  • Dahmen N, Marx J, Hopf HC, Tettenborn B, Roder R (1999) Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke 30:691–692.

    Article  PubMed  CAS  Google Scholar 

  • Dam M, Tonin P, De Boni A et al. (1996) Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27:1211–1214.

    Article  PubMed  CAS  Google Scholar 

  • Douyon R, Serby M, Klutchko B, Rotrosen J (1989) ECT and Parkinson’s disease revisited: a “naturalistic“ study. Am J Psychiatry 146:1451–1455.

    PubMed  CAS  Google Scholar 

  • Evans DL, Staab JP, Petitto JM et al. (1999) Depression in the medical setting: biopsychological interactions and treatment considerations. J Clin Psychiatry 60 (Suppl 4):40–55.

    PubMed  Google Scholar 

  • Falkai P, Kühn K-U, Maier W, Elger CE (2001) Psychopathology of pre- and postoperative patients with temporallobeepilepsy. (Submitted).

    Google Scholar 

  • Fedoroff JP, Lipsey JR, Starkstein SE, Forrester A, Price TR, Robinson RG (1991) Phenomenological comparisons of major depression following stroke, myocardial infarction or spinal cord lesions. J Affect Disord 22:83–89.

    Article  PubMed  CAS  Google Scholar 

  • Gainotti G, Azzoni A, Marra C (1999) Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry 175:163–167.

    Article  PubMed  CAS  Google Scholar 

  • Garnett WR (2000) Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 20:191–199.

    Article  Google Scholar 

  • Gordon WA, Hibbard MR (1997) Poststroke depression: an examination of the literature. Arch Phys Med Rehabil 78:658–663.

    Article  PubMed  CAS  Google Scholar 

  • Haltenhof H, Schröter C (1994) Depression beim Parkinson-Syndrom - eine Literatur0übersicht. Fortschr Neurol Psychiatr 62:94–101.

    Article  PubMed  CAS  Google Scholar 

  • Hantz P, Caradoc-Davies G, Caradoc-Davies T, Weatherall M, Dixon G (1994) Depression in Parkinson’s disease. Am J Psychiatry 151:1010–1014.

    PubMed  CAS  Google Scholar 

  • Helmstaedter C, Kurthen M, Lux S, Johanson K, Quiske A, Schramm J, Elger CE (2000) Temporallappenepilepsie. Längsschnittliche klinische, neuropsychologische und psychosoziale Entwicklung operativ und konservativ behandelter Patienten. Nervenarzt 71: 629–642.

    Article  PubMed  CAS  Google Scholar 

  • Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP (1998) The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke 29: 618–624.

    Article  PubMed  CAS  Google Scholar 

  • Hoogendijk WJ, Sommer IE, Tissingh G, Deeg Dj, Wolters EC (1998) Depression in Parkinson’s disease. The impact of symptom overlap on prevalence. Psychosomatics 39:416–421.

    CAS  Google Scholar 

  • Hopf HC, Schlegel S (1995) Depression im Gefolge von Hirninfarkten. In: Möller HJ, Przuntek H, Laux G, Büttner T (Hrsg) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin Heidelberg New York Tokyo.

    Google Scholar 

  • Hosking SG, Marsh NV, Friedman PJ (1996) Poststroke depression: prevalence, course, and associated factors. Neuropsychol Rev 6:107–133.

    Article  PubMed  CAS  Google Scholar 

  • Huber G (1974) Psychiatrie. Lehrbuch für Studium und Weiterbildung. Schattauer, Stuttgart.

    Google Scholar 

  • International League Against Epilepsy, ILAE (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30: 389–399.

    Google Scholar 

  • Janet P (1924) Leçons sur les Maladys du Système Nerveux. Delahaye, Paris.

    Google Scholar 

  • Klaassen T, Verhey FR, Sneijders GH, Rozendaal N, de Vet HC, van Praag HM (1995) Treatment of depression in Parkinson’s disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 7:281–286.

    PubMed  CAS  Google Scholar 

  • Kühn K-U, Quednow BB, Römer C, Falkai P, Elger CE, Maier W (2001) Antidepressive treatment in patients with temporallobeepilepsy. (Submitted).

    Google Scholar 

  • Levin BE, Katzen HL (1995) Early cognitive changes in Parkinson’s disease. In: Weiner WJ, Lang AE (eds) Behavioral neurology of movement disorders. Advances in Neurology. Raven, New York.

    Google Scholar 

  • Lewis AJ (1934) Melancholia: a historical review. J Ment Sci 80:1–42.

    Google Scholar 

  • Lipsey JR, Spencer WC, Rabins PV, Robinson RG (1986) Phenomenological comparison of poststroke depression and functional depression. Am J Psychiatry 143:527–529.

    PubMed  CAS  Google Scholar 

  • Maier W, Falkai P (1999) The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. Int Clin Psychopharmacol 14 (Suppl 2): 1–6.

    Google Scholar 

  • Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (1992) A population-based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender. Arch Neurol 49:492–497.

    CAS  Google Scholar 

  • Meschia JF, Bruno A (1998) Post-stroke complications, epidemiology and prospects for pharmacological intervention during rehabilitaton. CNS Drugs 9:357–370.

    Article  Google Scholar 

  • Mindham RH (1970) Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry 33:188–191.

    Article  PubMed  CAS  Google Scholar 

  • Morris PL, Robinson RG, Raphael B (1990) Prevalence and course of depressive disorders in hospitalized stroke patients. A double-blind placebo-controlled study. Int J Psychiatry Med 20:349–364.

    CAS  Google Scholar 

  • Murray GB, Shea V, Conn DK (1986) Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 47:258–260.

    PubMed  CAS  Google Scholar 

  • Neau JP, Ingrand P, Mouille-Brachet C, Rosier MP, Couderq C, Alvarez A, Gil R (1998) Functional recovery and social outcome after cerebral infarction in young adults. Cerbrovasc Dis 8:296–302.

    Article  CAS  Google Scholar 

  • Parkinson J (1817) An Essay on the Shaking Palsy. Sherwood, Neely & Jones, London.

    Google Scholar 

  • Poewe W, Luginger E (1999) Depression in Parkinson’s disease, Impediments to recognition and treatment options. Neurology 52 (Suppl 3):2–6.

    Google Scholar 

  • Robbins AH (1976) Depression in patients with Parkinsonism. Br J Psychiatry 128:141–145.

    Article  Google Scholar 

  • Robertson MM, Trimble MR, Townsend HR (1987) Phenomenology of depression in epilepsy. Epilepsia 28:364–372.

    Article  PubMed  CAS  Google Scholar 

  • Robertson MM, Katona CLE (eds) (1997) Depression and physical illness. Wiley, Chichester.

    Google Scholar 

  • Robinson RG, Travella JI (1996) Neuropsychiatry of mood disorders. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Davis, Baltimore.

    Google Scholar 

  • Robinson RG, Paradiso S (1999) Psychiatric aspects of cerebral vascular disorders. In: Robinson RG, Yates WE (eds) Psychiatric treatment of the medically ill. Dekker, New York.

    Google Scholar 

  • Santamaria J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible sub-group of idiopathic parkinsonism. Neurology 36:1130–1133.

    PubMed  CAS  Google Scholar 

  • Schubert DSP, Burns R, Paras W, Sioson E (1992) Increase of medical hospital length of stay by depression in stroke and amputation patients: a pilot study. Psychother Psychosom 57:61–66.

    Article  PubMed  CAS  Google Scholar 

  • Series HG (1992) Drug treatment of depression in medically ill patients. J Psychosom Res 36:1–16.

    Article  PubMed  CAS  Google Scholar 

  • Singh A, Black SE, Herrmann N, Leibovitch FS, Ebert PL, Lawrence J, Szalai JP (2000) Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stroke 31:637–644.

    Article  PubMed  CAS  Google Scholar 

  • Starkstein SE, Robinson RG (1989) Affective disorders and cerebral vascular disease. Br J Psychiatry 154:170–182.

    Article  PubMed  CAS  Google Scholar 

  • Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG (1990) Depression in Parkinson’s disease. J Nerv Ment Dis 178:27–31.

    Article  PubMed  CAS  Google Scholar 

  • Starkstein SE, Robinson RG (1992) Neuropsychiatric aspects of cerebral vascular disorders. In: Yudofsky SC, Hales RE (eds) Textbook of Neuropsychiatry, 2nd edn. American Psychiatric Press, Washington.

    Google Scholar 

  • Starkstein SE, Petracca G, Chemerinski E, Teson A, Sabe L, Merello M, Leiguarda R (1998) Depression in classic versus akinetic-rigid Parkinson’s disease. Mov Disord 13:29–33.

    Article  PubMed  CAS  Google Scholar 

  • Starkstein SE, Petracca G (1999) Parkinson’s Disease. In: Robinson RG, Yates WE (eds) Psychiatric treatment of the medically ill. Dekker, New York.

    Google Scholar 

  • Struppler A (2000) Erkrankungen der Basalganglien. In: Förstel H (Hrsg) Klinische Neuro-Psychiatrie: Thieme, Stuttgart.

    Google Scholar 

  • Tom T, Cummings JL (1999) Depression in Parkinson’s disease, pharmacological characteristics and treatment. Drugs Aging 12:55–74.

    Article  Google Scholar 

  • Walden J, Wegerer J, Berger M (1996) Wirksamkeit von Antiepileptika bei psychischen Erkrankungen. EEG-Labor 18:32–47.

    Google Scholar 

  • Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M (2000) Fluoxetine in early poststroke depression. Stroke 31:1829.

    CAS  Google Scholar 

  • Wettterling T (2000) Zerebrovaskuläre Erkrankungen. In: Förstel H (Hrsg) Klinische Neuro-Psychiatrie: Thieme, Stuttgart.

    Google Scholar 

  • Zesiewicz, TA, Gold M, Chari G, Hauser RA (1999) Current issues in depression in Parkinson’s disease. Am J Geriatr Psychiatry 7:110–118.

    PubMed  CAS  Google Scholar 

  • Ziegler B (1996) Zur Psychopathologie des Parkinson-Syndroms. Klinikarzt 9/25:266–270.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kühn, KU. (2002). Major Depression bei organischen Grunderkrankungen. In: Laux, G. (eds) Depression 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59394-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59394-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63963-0

  • Online ISBN: 978-3-642-59394-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics